Search alternatives:
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
mapk decrease » marked decrease (Expand Search), small decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
mapk decrease » marked decrease (Expand Search), small decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters
Published 2025“…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Table 2_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
10
Image 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.pdf
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
11
Table 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.docx
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
12
Data Sheet 1_SLC4A10 impedes atherosclerosis by diminishing IFN-γ/GZMB levels of CD8+ T cells via the MAPK pathway.zip
Published 2025“…</p>Conclusions<p>These data demonstrate that SLC4A10 mitigates cytotoxicity by decreasing the levels of IFN-γ/GZMB of SLC4A10<sup>+</sup> CD8<sup>+</sup> T cells via the MAPK pathway, which impedes plaque progression and aids stabilization.…”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20